Sara Sims, Ph.D., prepares and prosecutes US and foreign patent applications in the pharmaceutical and biotechnology fields, including nucleic acid therapeutics, immunotherapies, gene therapies, genome editing technologies, vaccines, diagnostics, antibodies, and pharmaceutical compositions and formulations. Sara also performs prior art searches and conducts patent portfolio reviews for due diligence projects, including freedom-to-operate assessments, patentability analyses, landscape evaluations, and loss of exclusivity studies.
Before becoming a patent agent, Sara earned her Ph.D. in biochemistry and molecular biology from Johns Hopkins University, where she worked in a yeast genetics lab to characterize the function and regulation of a pair of novel proteins as potential antifungal drug targets. She then completed a postdoctoral fellowship in the Genetics Department at Harvard University, where she received a Ruth L. Kirschstein Postdoctoral Fellowship from the National Institutes of Health. While in her postdoc, Sara used combined genetic, molecular biology, cytology, and biochemistry techniques to gain insight into the roles of histone-modifying enzymes in promoting accurate meiotic cell division in C. elegans.
Prior to joining Morgan Lewis, Sara was a patent agent at a Philadelphia IP boutique firm. She also worked as a patent agent at another full-service law firm in Philadelphia. She has co-authored several peer-reviewed journal articles in the fields of genetics, molecular biology, and biochemistry.
Harvard University Medical School, 2015, Postdoctoral Research Fellowship, Genetics
Johns Hopkins University, 2010, Ph.D., Biochemistry and Molecular Biology
Pennsylvania State University, 2005, B.S., Biochemistry and Molecular Biology, Chemistry minor, Schreyer Honors College
US Patent and Trademark Office
Awards and Affiliations
Ruth L. Kirschstein Postdoctoral Fellowship, National Institutes of General Medical Sciences of the National Institutes of Health